Semler Scientific Buys Additional 185 BTC for $20M, Bringing Holdings to 4,449 Bitcoin With 26.7% YTD Yield

Eric Semler, Chairman of Semler Scientific, added 185 BTC to SMLR BTC holdings. SMLR Scientific is known for medical tech solutions, has spent $20 million between May 23 and June 3, 2025. The average acquisition price was $107,974 per BTC. Semler confirmed this update via a June 4 post on X. The company’s total BTC holdings now stand at 4,449 BTC. Market value as of June 3 is $472.9 million, with a reported cost basis of $410 million. Semler has generated a 26.7% BTC yield year-to-date (YTD), further validating Bitcoin as a yield-generating treasury asset. This acquisition strengthens the trend of corporate BTC accumulation. It mirrors strategies used by firms like MicroStrategy, signaling institutional confidence in Bitcoin’s long-term value.

Semler Expands BTC Holdings Strategy

Semler continues to pivot toward Bitcoin adoption as a treasury strategy. SMLR has embraced Bitcoin as a reserve asset. The decision reflects growing acceptance of Bitcoin among traditional public firms. The latest purchase, 185 BTC, was acquired during a 12-day window ending June 3. The transaction raised Semler’s BTC holdings to 4,449 BTC. The company disclosed that the average acquisition price across all purchases is $92,158 per BTC. This calculated approach aligns with its strategic plan to optimize asset allocation using Bitcoin. The strategy positions Semler as one of the largest BTC holders outside the crypto-native space. This puts the company in line with high-profile firms pursuing similar treasury plays.

BTC Yield Highlights Strategic Returns

Semler reported a 26.7% BTC yield YTD as of June 3, 2025. This metric underscores the firm’s ability to use Bitcoin for generating shareholder value. This yield KPI measures how effectively Semler’s Bitcoin holdings are adding value. Demonstrating accretive growth and assessing the financial logic behind stock-funded BTC purchases. Yield returns reflect both capital appreciation and treasury strategy effectiveness. 

The company has positioned Bitcoin not just as a hedge, but as a performance tool. This trend supports Bitcoin’s growing role in corporate finance beyond passive investment. The firm uses its online Bitcoin Dashboard as a Regulation FD-compliant channel. The dashboard offers public access to BTC Yield, BTC Gain, acquisition cost, and other KPIs. Investors are urged to check the dashboard regularly for updates.

Institutional Signals and Market Outlook

Semler’s move reshapes the institutional Bitcoin adoption strategies. The acquisition follows a Controlled Equity Offering on April 15, 2025. This involves firms like Barclays, Cantor Fitzgerald, and Craig-Hallum. As of June 3, 2025, Semler raised $136.2 million via 3.54 million shares sold under the agreement. The funds are actively directed toward BTC accumulation. This reflects the institution’s view on Bitcoin as a global yield-bearing asset. Recent macroeconomic conditions, such as rising demand for non-correlated assets and declining real yields, are influencing treasury strategies. Semler’s approach aligns with this shift, particularly as regulatory clarity and market infrastructure mature.

Strategic BTC Holdings Reshape Corporate Finance

The scale and structure of Semler’s BTC holdings mark a notable pivot for a healthcare-focused public company. The firm’s strategy echoes MicroStrategy’s model, but with a unique operational background in medical diagnostics. Institutional demand for Bitcoin is growing amid the search for performance-linked assets. Semler’s integration of BTC into its treasury model indicates Bitcoin’s evolution into mainstream financial planning.

Market watchers now track Semler’s BTC dashboard for real-time performance updates. With its current holdings valued at $472.9 million, Semler strengthens the corporate use case for Bitcoin as a strategic, high-yield asset. As the market adapts to this shift, Semler’s decisions may influence similar public companies to consider Bitcoin in their treasury strategies.